Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Immature central tumor tertiary lymphoid structures are associated with better prognosis in non-small cell lung cancer

View through CrossRef
Abstract Background & aims: Tertiary lymphoid structures (TLSs[1]) are predictive biomarkers of favorable clinical outcomes and immunotherapy response in several solid malignancies, including non-small cell lung cancer (NSCLC). However, the relationship between TLSs and NSCLC prognosis has not been eludicated from the aspects of location, density, and maturity. This study aimed to investigate the clinicopathological and prognostic significance of TLSs in NSCLC. Methods: A collection of 151resected pulmonary nodules in patients with NSCLC was retrospectively analyzed. Two experienced pathologists reviewed hematoxylin-eosin (H&E) slides and assessed TLS scores at different anatomic subregions. Then, we analyzed their correlation with clinicopathologic parameters and CD8 staining intensity and assessed multiple clinicopathological factors affecting patient prognosis. Results: CD8 expression was correlated with total (TLS-CT) (P = 0.000), aggregates (Agg) (TLS-CT) (P = 0.001), follicles (FOL)-I (TLS-CT) (P= 0.025), and TLS(overall) (P = 0.013). TLS scores in the central tumor (CT) and invasion margin (IM) areas were negatively correlated with distant metastasis and Union for International Cancer Control (UICC) stage in NSCLC patients, while TLS score in the CT area was positively correlated with CD8 expression. TLS (overall), Agg (TLS-CT), and FOL-I (TLS-CT) were positively correlated with distant metastasis, UICC stage, and CD8 expression in NSCLC patients. Agg (TLS-IM) was positively correlated with distant metastasis and UICC stage. FOL-I (TLS-IM) was positively correlated with UICC stage. FOL-II (TLS-IM) was positively correlated with distant metastasis (P < 0.05). Multivariate Cox regression analysis showed that unfavorable independent prognostic factors were associated with metastasis status and UICC stage. Independent prognostic factors with protective effects included Agg (TLS-CT), FOL-I (TLS-CT), total (TLS-CT), and overall TLS (P < 0.05). Conclusion: Histological score assessment of H&E sections of Agg (TLS-CT), FOL-I (TLS-CT), total (TLS-CT), and overall TLS levels in NSCLC has prognostic value. [1]Abbreviations: Agg, aggregates; CI, confidence interval; CT, central tumor; FOL, follicles; H&E, hematoxylin–eosin; HR, hazard ratio; IM, invasive margin; IM, invasion margin; LSCC, lung squamous cell carcinoma; LUAD, lung adenocarcinoma; NSCLC, non-small cell lung cancer; OS, overall survival; SCLC, small cell lung cancer; TLS, tertiary lymphoid structure; TLT, tertiary lymphoid tissue; UICC, Union for International Cancer Control
Research Square Platform LLC
Title: Immature central tumor tertiary lymphoid structures are associated with better prognosis in non-small cell lung cancer
Description:
Abstract Background & aims: Tertiary lymphoid structures (TLSs[1]) are predictive biomarkers of favorable clinical outcomes and immunotherapy response in several solid malignancies, including non-small cell lung cancer (NSCLC).
However, the relationship between TLSs and NSCLC prognosis has not been eludicated from the aspects of location, density, and maturity.
This study aimed to investigate the clinicopathological and prognostic significance of TLSs in NSCLC.
Methods: A collection of 151resected pulmonary nodules in patients with NSCLC was retrospectively analyzed.
Two experienced pathologists reviewed hematoxylin-eosin (H&E) slides and assessed TLS scores at different anatomic subregions.
Then, we analyzed their correlation with clinicopathologic parameters and CD8 staining intensity and assessed multiple clinicopathological factors affecting patient prognosis.
Results: CD8 expression was correlated with total (TLS-CT) (P = 0.
000), aggregates (Agg) (TLS-CT) (P = 0.
001), follicles (FOL)-I (TLS-CT) (P= 0.
025), and TLS(overall) (P = 0.
013).
TLS scores in the central tumor (CT) and invasion margin (IM) areas were negatively correlated with distant metastasis and Union for International Cancer Control (UICC) stage in NSCLC patients, while TLS score in the CT area was positively correlated with CD8 expression.
TLS (overall), Agg (TLS-CT), and FOL-I (TLS-CT) were positively correlated with distant metastasis, UICC stage, and CD8 expression in NSCLC patients.
Agg (TLS-IM) was positively correlated with distant metastasis and UICC stage.
FOL-I (TLS-IM) was positively correlated with UICC stage.
FOL-II (TLS-IM) was positively correlated with distant metastasis (P < 0.
05).
Multivariate Cox regression analysis showed that unfavorable independent prognostic factors were associated with metastasis status and UICC stage.
Independent prognostic factors with protective effects included Agg (TLS-CT), FOL-I (TLS-CT), total (TLS-CT), and overall TLS (P < 0.
05).
Conclusion: Histological score assessment of H&E sections of Agg (TLS-CT), FOL-I (TLS-CT), total (TLS-CT), and overall TLS levels in NSCLC has prognostic value.
[1]Abbreviations: Agg, aggregates; CI, confidence interval; CT, central tumor; FOL, follicles; H&E, hematoxylin–eosin; HR, hazard ratio; IM, invasive margin; IM, invasion margin; LSCC, lung squamous cell carcinoma; LUAD, lung adenocarcinoma; NSCLC, non-small cell lung cancer; OS, overall survival; SCLC, small cell lung cancer; TLS, tertiary lymphoid structure; TLT, tertiary lymphoid tissue; UICC, Union for International Cancer Control.

Related Results

Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Abstract Introduction Sacrococcygeal teratoma (SCT) is a rare embryonal tumor that occurs in the sacrococcygeal region, with an incidence of about 1 in 35,000 to 40,000 live births...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract Introduction  Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Abstract Introduction Non-Hodgkin lymphoma (NHL) of the thyroid, a rare malignancy linked to autoimmune disorders, is poorly understood in terms of its pathogenesis and treatment o...
Abstract 1345: Evidence for genetic mediation of lung cancer through hay fever.
Abstract 1345: Evidence for genetic mediation of lung cancer through hay fever.
Abstract Introduction: In the past decade, advances in genetics have led to the discovery of numerous lung cancer susceptibility variants. The majority of these vari...
Medical costs of Japanese lung cancer patients during end-of-life care
Medical costs of Japanese lung cancer patients during end-of-life care
Abstract Objective The medical costs associated with cancer treatment have increased rapidly in Japan; however, little data exis...
Abstract 1108: Evaluation of heme inhibitory therapy in combination with chemotherapy drugs on SCLC progression
Abstract 1108: Evaluation of heme inhibitory therapy in combination with chemotherapy drugs on SCLC progression
Abstract Lung cancer is the leading cause of cancer-related death in the US. It is mainly divided in two types: small cell lung cancer and non-small cell lung cancer...

Back to Top